Adrenocortical carcinoma is a rare, aggressive malignancy that features a correspondingly poor prognosis.
The disease accounts for 0.2% of all malignancies and despite multimodal therapies, its prognosis remains poor, with a mean survival of < 30 months. This paper reports on a patient submitted to surgical resection and adjuvant chemotherapy for adrenocortical carcinoma with an ongoing follow-up of 8 months after surgery and no signs of recurrence.
Written by:
Siosaki MD, Pelafsky L, Fonseca Siosaki AT, Garcia LR. Are you the author?
Surgical Oncology Department, Hospital Estadual Bauru, Bauru, Brazil.
Reference: Case Rep Oncol. 2014 Mar 20;7(1):222-7.
doi: 10.1159/000362161
PubMed Abstract
PMID: 24803899
UroToday.com Adrenal and Kidney Conditions Section
